{"transactions":[{"id":2120461,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2022-11-10T21:12:26.000Z","date":"2022-11-08","kind":"sale","acquired":false,"shares":4546352,"ownership":{"direct":false,"nature":"Owned through wholly owned corporations"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold to RCH Holdings Six Inc. by Perelman Trust Company, LLC, over which MacAndrews & Forbes Incorporated (\"M&F\") exercises voting control, in exchange for cash consideration of $45,463.52.  Mr. Perelman is the sole stockholder of M&F. The transaction was effectuated to implement certain philanthropic endeavors for Mr. Perelman."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the 41,676,969 shares of Class A Common Stock reported herein, (i) 36,470,036 shares of Class A Common Stock are owned by M&F or its wholly owned subsidiaries; and (ii) 5,206,933 shares of Class A Common Stock are owned by RCH Holdings Five Inc."}],"balance_after":41676969,"source":{"system":"sec-edgar","filing":"0001140361-22-041084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887921/000114036122041084/form4.xml","form_type":"4"}},{"id":2462233,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-21T16:51:47.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":87000,"price":1.15,"value":100050.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). The ROP Revocable Trust is also the sole stockholder of Thirty Six East Corporation (\"Thirty Six East\"). M&F Group, MFV and Thirty Six East hold the securities described above. (cont'd on FN 2)"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"(cont'd from FN 1) Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group, MFV and Thirty Six East may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of the role of Rich Nelson, director of the Issuer, as Executive Vice President Corporate and Business Development of Vericast and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":36519212,"source":{"system":"sec-edgar","filing":"0000950142-21-004124","document":"es210212345_4-perelman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000095014221004124/es210212345_4-perelman.xml","form_type":"4"}},{"id":2933666,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-23T17:03:57.000Z","date":"2020-12-22","kind":"other","acquired":false,"shares":5206933,"ownership":{"direct":false,"nature":"Owned through wholly owned corporations"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were transferred to a holding company in which The ROP Revocable Trust dated 1/9/2018 and The Ronald O. Perelman 2020 Trust each own 50% of the shares called RCH Holdings Five Inc., in exchange for cash consideration of $7,640,068 and notes with aggregate principal amount of $43,293,717 payable to subsidiaries of MacAndrews & Forbes Incorporated (\"M&F\"). Mr. Perelman is the sole trustee of The Revocable Trust dated 1/9/2018 and is the settlor of The Ronald O. Perelman 2020 Trust. The transaction was effectuated to implement certain estate planning matters for Mr. Perelman."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were transferred to a holding company in which The ROP Revocable Trust dated 1/9/2018 and The Ronald O. Perelman 2020 Trust each own 50% of the shares called RCH Holdings Five Inc., in exchange for cash consideration of $7,640,068 and notes with aggregate principal amount of $43,293,717 payable to subsidiaries of MacAndrews & Forbes Incorporated (\"M&F\"). Mr. Perelman is the sole trustee of The Revocable Trust dated 1/9/2018 and is the settlor of The Ronald O. Perelman 2020 Trust. The transaction was effectuated to implement certain estate planning matters for Mr. Perelman."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the 46,223,321 shares of Class A Common Stock reported herein, (i) 36,470,036 shares of Class A Common Stock are owned by M&F or its wholly-owned subsidiaries; (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control; and (iii) 5,206,933 shares of Class A Common Stock are owned by RCH Holdings Five Inc."}],"balance_after":46223321,"source":{"system":"sec-edgar","filing":"0001209191-20-065042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919120065042/doc4.xml","form_type":"4"}},{"id":2933665,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-23T17:03:57.000Z","date":"2020-12-22","kind":"other","acquired":true,"shares":5206933,"ownership":{"direct":false,"nature":"Owned through RCH Holdings Five Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were transferred to a holding company in which The ROP Revocable Trust dated 1/9/2018 and The Ronald O. Perelman 2020 Trust each own 50% of the shares called RCH Holdings Five Inc., in exchange for cash consideration of $7,640,068 and notes with aggregate principal amount of $43,293,717 payable to subsidiaries of MacAndrews & Forbes Incorporated (\"M&F\"). Mr. Perelman is the sole trustee of The Revocable Trust dated 1/9/2018 and is the settlor of The Ronald O. Perelman 2020 Trust. The transaction was effectuated to implement certain estate planning matters for Mr. Perelman."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were transferred to a holding company in which The ROP Revocable Trust dated 1/9/2018 and The Ronald O. Perelman 2020 Trust each own 50% of the shares called RCH Holdings Five Inc., in exchange for cash consideration of $7,640,068 and notes with aggregate principal amount of $43,293,717 payable to subsidiaries of MacAndrews & Forbes Incorporated (\"M&F\"). Mr. Perelman is the sole trustee of The Revocable Trust dated 1/9/2018 and is the settlor of The Ronald O. Perelman 2020 Trust. The transaction was effectuated to implement certain estate planning matters for Mr. Perelman."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the 46,223,321 shares of Class A Common Stock reported herein, (i) 36,470,036 shares of Class A Common Stock are owned by M&F or its wholly-owned subsidiaries; (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control; and (iii) 5,206,933 shares of Class A Common Stock are owned by RCH Holdings Five Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares were transferred to a holding company in which The ROP Revocable Trust dated 1/9/2018 and The Ronald O. Perelman 2020 Trust each own 50% of the shares called RCH Holdings Five Inc., in exchange for cash consideration of $7,640,068 and notes with aggregate principal amount of $43,293,717 payable to subsidiaries of MacAndrews & Forbes Incorporated (\"M&F\"). Mr. Perelman is the sole trustee of The Revocable Trust dated 1/9/2018 and is the settlor of The Ronald O. Perelman 2020 Trust. The transaction was effectuated to implement certain estate planning matters for Mr. Perelman."}],"balance_after":46223321,"source":{"system":"sec-edgar","filing":"0001209191-20-065042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919120065042/doc4.xml","form_type":"4"}},{"id":2939718,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2020-12-17T17:02:21.000Z","date":"2020-12-17","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 17, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 17, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 17, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001140361-20-028743","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120028743/form4.xml","form_type":"4"}},{"id":2939717,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2020-12-17T17:02:21.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":625000,"price":1.6,"value":1000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":36606212,"source":{"system":"sec-edgar","filing":"0001140361-20-028743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120028743/form4.xml","form_type":"4"}},{"id":2949913,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2020-12-10T16:45:32.000Z","date":"2020-12-10","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 10, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 10, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 10, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001140361-20-028037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120028037/form4.xml","form_type":"4"}},{"id":2949912,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2020-12-10T16:45:32.000Z","date":"2020-12-10","kind":"purchase","acquired":true,"shares":625000,"price":1.6,"value":1000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":35981212,"source":{"system":"sec-edgar","filing":"0001140361-20-028037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120028037/form4.xml","form_type":"4"}},{"id":2967749,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2020-11-24T16:45:35.000Z","date":"2020-11-24","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 24, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 24, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 24, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001140361-20-026446","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120026446/form4.xml","form_type":"4"}},{"id":2967748,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2020-11-24T16:45:35.000Z","date":"2020-11-24","kind":"purchase","acquired":true,"shares":625000,"price":1.6,"value":1000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":35356212,"source":{"system":"sec-edgar","filing":"0001140361-20-026446","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120026446/form4.xml","form_type":"4"}},{"id":3008974,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Former Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-13T20:56:31.000Z","date":"2020-10-12","kind":"sale","acquired":false,"shares":1964285,"price":28,"value":54999980.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 122,728 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman does not own any shares of Common Stock directly. On October 12, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC and SGMS Acquisition Three LLC sold an aggregate of 1,964,285 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC."}],"balance_after":8871313,"source":{"system":"sec-edgar","filing":"0001209191-20-054669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120054669/doc4.xml","form_type":"4"}},{"id":3010472,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Former Executive Chairman"}}],"security":"Common Stock","published_at":"2020-10-08T20:37:15.000Z","date":"2020-10-07","kind":"sale","acquired":false,"shares":2499999,"price":28,"value":69999972.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 122,728 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman does not own any shares of Common Stock directly. On October 7, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC and SGMS Acquisition Two LLC sold an aggregate of 2,499,999 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC."}],"balance_after":10835598,"source":{"system":"sec-edgar","filing":"0001209191-20-054282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120054282/doc4.xml","form_type":"4"}},{"id":3020409,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Former Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-30T21:17:53.000Z","date":"2020-09-30","kind":"sale","acquired":false,"shares":4700000,"price":28,"value":131600000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 105,624 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman also directly owns 17,104 shares of Common Stock. On September 30, 2020, SGMS Acquisition Corporation and RLX Holdings Two LLC sold an aggregate of 4,700,000 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC."}],"balance_after":13318493,"source":{"system":"sec-edgar","filing":"0001209191-20-052475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120052475/doc4.xml","form_type":"4"}},{"id":3021447,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Former Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-29T21:08:54.000Z","date":"2020-09-28","kind":"sale","acquired":false,"shares":9417062,"price":28,"value":263677736.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 105,624 shares of Common Stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. Mr. Perelman also directly owns 17,104 shares of Common Stock. On September 28, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC and SGMS Acquisition Two LLC sold an aggregate of 9,417,062 shares of Common Stock pursuant to the previously disclosed Stock Purchase Agreement by and among SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC, MacAndrews & Forbes Group, LLC and Pivot Buyer LLC."}],"balance_after":18018493,"source":{"system":"sec-edgar","filing":"0001209191-20-052359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120052359/doc4.xml","form_type":"4"}},{"id":3030845,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-09-16T21:32:46.000Z","date":"2020-09-16","kind":"exercise","acquired":false,"shares":8372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents vesting of the restricted stock units granted on June 10, 2020 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents vesting of the restricted stock units granted on June 10, 2020 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents vesting of the restricted stock units granted on June 10, 2020 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8372},"source":{"system":"sec-edgar","filing":"0001209191-20-050743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120050743/doc4.xml","form_type":"4"}},{"id":3030844,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-09-16T21:32:46.000Z","date":"2020-09-16","kind":"exercise","acquired":false,"shares":5783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents vesting of the remaining restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents vesting of the remaining restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents vesting of the remaining restricted stock units granted on June 12, 2019 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5783},"source":{"system":"sec-edgar","filing":"0001209191-20-050743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120050743/doc4.xml","form_type":"4"}},{"id":3030843,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-09-16T21:32:46.000Z","date":"2020-09-16","kind":"exercise","acquired":false,"shares":1394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents vesting of the remaining restricted stock units granted on June 13, 2018 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 as described above. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1394},"source":{"system":"sec-edgar","filing":"0001209191-20-050743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120050743/doc4.xml","form_type":"4"}},{"id":3030842,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-09-16T21:32:46.000Z","date":"2020-09-16","kind":"exercise","acquired":false,"shares":1555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 in connection with the transactions provided for in the Stock Purchase Agreement. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 in connection with the transactions provided for in the Stock Purchase Agreement. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents vesting of the remaining restricted stock units granted on June 19, 2017 in connection with the conclusion of Mr. Perelman's service as a director on September 16, 2020 in connection with the transactions provided for in the Stock Purchase Agreement. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1555},"source":{"system":"sec-edgar","filing":"0001209191-20-050743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120050743/doc4.xml","form_type":"4"}},{"id":3030841,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-16T21:32:46.000Z","date":"2020-09-16","kind":"sale","acquired":false,"shares":9375806,"price":28,"value":262522568.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 105,624 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above. On September 16, 2020, SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC sold an aggregate of 9,375,806 shares of Common Stock pursuant to a Stock Purchase Agreement with Pivot Buyer LLC (the \"Stock Purchase Agreement\")."}],"balance_after":27435554,"source":{"system":"sec-edgar","filing":"0001209191-20-050743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120050743/doc4.xml","form_type":"4"}},{"id":3030840,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-09-16T21:32:46.000Z","date":"2020-09-16","kind":"exercise","acquired":true,"shares":17104,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17104,"source":{"system":"sec-edgar","filing":"0001209191-20-050743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000120919120050743/doc4.xml","form_type":"4"}},{"id":3104892,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-06-19T20:34:00.000Z","date":"2020-06-19","kind":"exercise","acquired":false,"shares":1555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest on June 19, 2021. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest on June 19, 2021. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest on June 19, 2021. Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":1555,"derivative":{"underlying":"Common Stock","underlying_shares":1555},"source":{"system":"sec-edgar","filing":"0000750004-20-000108","document":"wf-form4_159259881921710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000108/wf-form4_159259881921710.xml","form_type":"4"}},{"id":3104891,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-19T20:34:00.000Z","date":"2020-06-19","kind":"exercise","acquired":true,"shares":1555,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8518,"source":{"system":"sec-edgar","filing":"0000750004-20-000108","document":"wf-form4_159259881921710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000108/wf-form4_159259881921710.xml","form_type":"4"}},{"id":3111261,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-06-15T20:32:59.000Z","date":"2020-06-15","kind":"exercise","acquired":false,"shares":4339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."}],"balance_after":8371,"derivative":{"underlying":"Common Stock","underlying_shares":4339},"source":{"system":"sec-edgar","filing":"0000750004-20-000098","document":"wf-form4_159225316152578.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000098/wf-form4_159225316152578.xml","form_type":"4"}},{"id":3111260,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-06-15T20:32:59.000Z","date":"2020-06-13","kind":"exercise","acquired":false,"shares":697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 13, 2018. The balance of the award is scheduled to vest in equal installments of 697 shares on each of June 13, 2021 and June 13, 2022. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 13, 2018. The balance of the award is scheduled to vest in equal installments of 697 shares on each of June 13, 2021 and June 13, 2022. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 13, 2018. The balance of the award is scheduled to vest in equal installments of 697 shares on each of June 13, 2021 and June 13, 2022. Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":1394,"derivative":{"underlying":"Common Stock","underlying_shares":697},"source":{"system":"sec-edgar","filing":"0000750004-20-000098","document":"wf-form4_159225316152578.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000098/wf-form4_159225316152578.xml","form_type":"4"}},{"id":3111259,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-15T20:32:59.000Z","date":"2020-06-15","kind":"exercise","acquired":true,"shares":4339,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6963,"source":{"system":"sec-edgar","filing":"0000750004-20-000098","document":"wf-form4_159225316152578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000098/wf-form4_159225316152578.xml","form_type":"4"}},{"id":3111258,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-15T20:32:59.000Z","date":"2020-06-13","kind":"exercise","acquired":true,"shares":697,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2624,"source":{"system":"sec-edgar","filing":"0000750004-20-000098","document":"wf-form4_159225316152578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000098/wf-form4_159225316152578.xml","form_type":"4"}},{"id":3112668,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-06-12T20:32:09.000Z","date":"2020-06-12","kind":"exercise","acquired":false,"shares":1927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 12, 2019. The balance of the award is scheduled to vest in three installments on June 12, 2021 (1,928 shares), June 12, 2022 (1,927 shares) and June 12, 2023 (1,928 shares). Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 12, 2019. The balance of the award is scheduled to vest in three installments on June 12, 2021 (1,928 shares), June 12, 2022 (1,927 shares) and June 12, 2023 (1,928 shares). Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 12, 2019. The balance of the award is scheduled to vest in three installments on June 12, 2021 (1,928 shares), June 12, 2022 (1,927 shares) and June 12, 2023 (1,928 shares). Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":5783,"derivative":{"underlying":"Common Stock","underlying_shares":1927},"source":{"system":"sec-edgar","filing":"0000750004-20-000083","document":"wf-form4_159199391229280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000083/wf-form4_159199391229280.xml","form_type":"4"}},{"id":3112667,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-06-12T20:32:09.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":8372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units are scheduled to vest in four equal annual installments beginning on June 10, 2021. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are scheduled to vest in four equal annual installments beginning on June 10, 2021. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units are scheduled to vest in four equal annual installments beginning on June 10, 2021. Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":8372,"derivative":{"underlying":"Common Stock","underlying_shares":8372},"source":{"system":"sec-edgar","filing":"0000750004-20-000083","document":"wf-form4_159199391229280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000083/wf-form4_159199391229280.xml","form_type":"4"}},{"id":3112666,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-06-12T20:32:09.000Z","date":"2020-06-12","kind":"exercise","acquired":true,"shares":1927,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1927,"source":{"system":"sec-edgar","filing":"0000750004-20-000083","document":"wf-form4_159199391229280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000420000083/wf-form4_159199391229280.xml","form_type":"4"}},{"id":3152376,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2020-05-12T16:32:46.000Z","date":"2020-05-12","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On May 12, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On May 12, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On May 12, 2020, the Issuer exercised its right to have M&F Group purchase 625,000 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001140361-20-011442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120011442/form4.xml","form_type":"4"}},{"id":3152375,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2020-05-12T16:32:46.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":625000,"price":1.6,"value":1000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":34731212,"source":{"system":"sec-edgar","filing":"0001140361-20-011442","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120011442/form4.xml","form_type":"4"}},{"id":3248752,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2020-02-25T16:30:30.000Z","date":"2020-02-25","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On February 25, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On February 25, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On February 25, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001140361-20-004007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120004007/form4.xml","form_type":"4"}},{"id":3248751,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2020-02-25T16:30:30.000Z","date":"2020-02-25","kind":"purchase","acquired":true,"shares":1250000,"price":1.6,"value":2000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":34106212,"source":{"system":"sec-edgar","filing":"0001140361-20-004007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120004007/form4.xml","form_type":"4"}},{"id":3299992,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2020-01-28T16:31:33.000Z","date":"2020-01-28","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 28, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 28, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 28, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001140361-20-001599","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120001599/form4.xml","form_type":"4"}},{"id":3299991,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2020-01-28T16:31:33.000Z","date":"2020-01-28","kind":"purchase","acquired":true,"shares":1250000,"price":1.6,"value":2000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":32856212,"source":{"system":"sec-edgar","filing":"0001140361-20-001599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120001599/form4.xml","form_type":"4"}},{"id":3316088,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2020-01-07T16:16:14.000Z","date":"2020-01-07","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 7, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 7, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On January 7, 2020, the Issuer exercised its right to have M&F Group purchase 1,250,000 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001140361-20-000401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120000401/form4.xml","form_type":"4"}},{"id":3316087,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2020-01-07T16:16:14.000Z","date":"2020-01-07","kind":"purchase","acquired":true,"shares":1250000,"price":1.6,"value":2000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of MacAndrews & Forbes Group LLC (\"M&F Group\"). M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":31606212,"source":{"system":"sec-edgar","filing":"0001140361-20-000401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036120000401/form4.xml","form_type":"4"}},{"id":3332322,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Common Stock Purchase Warrant","published_at":"2019-12-23T16:15:41.000Z","date":"2019-12-23","kind":"other","acquired":true,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the \"Warrant\") to purchase 365,472 shares of Common Stock, exercisable at a price of $1.84, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until December 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the \"Warrant\") to purchase 365,472 shares of Common Stock, exercisable at a price of $1.84, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until December 23, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the \"Warrant\") to purchase 365,472 shares of Common Stock, exercisable at a price of $1.84, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until December 23, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.84,"exercise_date":"2019-12-23","expiration_date":"2026-12-23","underlying":"Class A common stock","underlying_shares":365472},"source":{"system":"sec-edgar","filing":"0001140361-19-023102","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119023102/form4.xml","form_type":"4"}},{"id":3332321,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-12-23T16:15:41.000Z","date":"2019-12-23","kind":"other","acquired":true,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 23, 2019, MacAndrews & Forbes Group LLC (\"M&F Group\") entered into a letter agreement (the \"Letter Agreement\"), with vTv Therapeutics Inc. (the \"Issuer\") for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 23, 2019, MacAndrews & Forbes Group LLC (\"M&F Group\") entered into a letter agreement (the \"Letter Agreement\"), with vTv Therapeutics Inc. (the \"Issuer\") for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 23, 2019, MacAndrews & Forbes Group LLC (\"M&F Group\") entered into a letter agreement (the \"Letter Agreement\"), with vTv Therapeutics Inc. (the \"Issuer\") for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Issuer's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.60. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.6,"exercise_date":"2019-12-23","expiration_date":"2020-12-23","underlying":"Class A common stock","underlying_shares":6250000},"source":{"system":"sec-edgar","filing":"0001140361-19-023102","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119023102/form4.xml","form_type":"4"}},{"id":3336521,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-12-18T16:15:36.000Z","date":"2019-12-18","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 18, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 18, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On December 18, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.46,"exercise_date":"2019-09-26","expiration_date":"2020-09-26","underlying":"Class A common stock","underlying_shares":1369863},"source":{"system":"sec-edgar","filing":"0001140361-19-022838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119022838/form4.xml","form_type":"4"}},{"id":3336520,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-12-18T16:15:36.000Z","date":"2019-12-18","kind":"purchase","acquired":true,"shares":1369863,"price":1.46,"value":1999999.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":30356212,"source":{"system":"sec-edgar","filing":"0001140361-19-022838","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119022838/form4.xml","form_type":"4"}},{"id":3358598,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-11-26T16:15:36.000Z","date":"2019-11-26","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 26, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 26, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 26, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.46,"exercise_date":"2019-09-26","expiration_date":"2020-09-26","underlying":"Class A common stock","underlying_shares":1369863},"source":{"system":"sec-edgar","filing":"0001140361-19-021508","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119021508/form4.xml","form_type":"4"}},{"id":3358597,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-11-26T16:15:36.000Z","date":"2019-11-26","kind":"purchase","acquired":true,"shares":1369863,"price":1.46,"value":1999999.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":28986349,"source":{"system":"sec-edgar","filing":"0001140361-19-021508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119021508/form4.xml","form_type":"4"}},{"id":3374202,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-11-12T16:26:48.000Z","date":"2019-11-12","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 12, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 12, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On November 12, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.46,"exercise_date":"2019-09-26","expiration_date":"2020-09-26","underlying":"Class A common stock","underlying_shares":1369863},"source":{"system":"sec-edgar","filing":"0001140361-19-020346","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119020346/form4.xml","form_type":"4"}},{"id":3374201,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-11-12T16:26:48.000Z","date":"2019-11-12","kind":"purchase","acquired":true,"shares":1369863,"price":1.46,"value":1999999.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":27616486,"source":{"system":"sec-edgar","filing":"0001140361-19-020346","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119020346/form4.xml","form_type":"4"}},{"id":3388610,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-10-24T19:11:21.000Z","date":"2019-10-24","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On October 24, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On October 24, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On October 24, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.46,"exercise_date":"2019-09-26","expiration_date":"2020-09-26","underlying":"Class A common stock","underlying_shares":1369863},"source":{"system":"sec-edgar","filing":"0001140361-19-019008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119019008/form4.xml","form_type":"4"}},{"id":3388609,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-10-24T19:11:21.000Z","date":"2019-10-24","kind":"purchase","acquired":true,"shares":1369863,"price":1.46,"value":1999999.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":26246623,"source":{"system":"sec-edgar","filing":"0001140361-19-019008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119019008/form4.xml","form_type":"4"}},{"id":3403916,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-10-01T23:07:11.000Z","date":"2019-09-30","kind":"purchase","acquired":true,"shares":50000,"price":20.42,"value":1021000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades at prices ranging from $20.30 to $20.51. The price reported above reflects the weighted average purchase price.  Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 88,032 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above."}],"balance_after":36793768,"source":{"system":"sec-edgar","filing":"0000950157-19-001131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719001131/form4.xml","form_type":"4"}},{"id":3405646,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-09-27T22:34:20.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":100000,"price":20.83,"value":2083000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades at prices ranging from $20.47 to $20.98. The price reported above reflects the weighted average purchase price.  Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 88,032 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above."}],"balance_after":36743768,"source":{"system":"sec-edgar","filing":"0000950157-19-001106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719001106/form4.xml","form_type":"4"}},{"id":3405119,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-09-27T16:31:00.000Z","date":"2019-09-27","kind":"other","acquired":false,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.46,"exercise_date":"2019-09-26","expiration_date":"2020-09-26","underlying":"Class A common stock","underlying_shares":1369863},"source":{"system":"sec-edgar","filing":"0001140361-19-017447","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119017447/form4.xml","form_type":"4"}},{"id":3405118,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Common Stock Purchase Warrant","published_at":"2019-09-27T16:31:00.000Z","date":"2019-09-26","kind":"other","acquired":true,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the \"Warrant\") to purchase 400,990 shares of Common Stock, exercisable at a price of $1.68, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until September 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the \"Warrant\") to purchase 400,990 shares of Common Stock, exercisable at a price of $1.68, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until September 26, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In consideration for the commitment of M&F Group under the Letter Agreement, the Issuer issued M&F Group a warrant (the \"Warrant\") to purchase 400,990 shares of Common Stock, exercisable at a price of $1.68, which is 115% of the option price under the Letter Agreement. The Warrant is exercisable until September 26, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.68,"exercise_date":"2019-09-26","expiration_date":"2026-09-26","underlying":"Class A common stock","underlying_shares":400990},"source":{"system":"sec-edgar","filing":"0001140361-19-017447","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119017447/form4.xml","form_type":"4"}},{"id":3405117,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-09-27T16:31:00.000Z","date":"2019-09-26","kind":"other","acquired":true,"shares":1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 26, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\"), at a per share price of $1.46. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On September 27, 2019, the Issuer exercised its right to have M&F Group purchase 1,369,863 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.46,"exercise_date":"2019-09-26","expiration_date":"2020-09-26","underlying":"Class A common stock","underlying_shares":6849315},"source":{"system":"sec-edgar","filing":"0001140361-19-017447","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119017447/form4.xml","form_type":"4"}},{"id":3405116,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-09-27T16:31:00.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":1369863,"price":1.46,"value":1999999.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":24876760,"source":{"system":"sec-edgar","filing":"0001140361-19-017447","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119017447/form4.xml","form_type":"4"}},{"id":3408670,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-09-23T21:01:52.000Z","date":"2019-09-20","kind":"purchase","acquired":true,"shares":100000,"price":22.98,"value":2298000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades at prices ranging from $22.55 to $23.15. The price reported above reflects the weighted average purchase price.  Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 88,032 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above."}],"balance_after":36643768,"source":{"system":"sec-edgar","filing":"0000950157-19-001057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719001057/form4.xml","form_type":"4"}},{"id":3411539,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-09-19T00:34:02.000Z","date":"2019-09-18","kind":"purchase","acquired":true,"shares":100000,"price":22.41,"value":2241000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades at prices ranging from $21.83 to $22.62. The price reported above reflects the weighted average purchase price.  Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Perelman is the sole beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 88,032 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above."}],"balance_after":36543768,"source":{"system":"sec-edgar","filing":"0000950157-19-001047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719001047/form4.xml","form_type":"4"}},{"id":3410621,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-09-18T16:40:32.000Z","date":"2019-09-18","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On September 18, 2019, the Issuer exercised its right to have M&F Group purchase 606,061 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On September 18, 2019, the Issuer exercised its right to have M&F Group purchase 606,061 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.65,"exercise_date":"2019-03-18","expiration_date":"2020-03-18","underlying":"Class A common stock","underlying_shares":606061},"source":{"system":"sec-edgar","filing":"0001140361-19-016918","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119016918/form4.xml","form_type":"4"}},{"id":3410620,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-09-18T16:40:32.000Z","date":"2019-09-18","kind":"purchase","acquired":true,"shares":606061,"price":1.65,"value":1000000.65,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":23506897,"source":{"system":"sec-edgar","filing":"0001140361-19-016918","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119016918/form4.xml","form_type":"4"}},{"id":3417305,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-09-11T16:42:23.000Z","date":"2019-09-11","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On September 11, 2019, the Issuer exercised its right to have M&F Group purchase 606,061 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On September 11, 2019, the Issuer exercised its right to have M&F Group purchase 606,061 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.65,"exercise_date":"2019-03-18","expiration_date":"2020-03-18","underlying":"Class A common stock","underlying_shares":606061},"source":{"system":"sec-edgar","filing":"0001140361-19-016526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119016526/form4.xml","form_type":"4"}},{"id":3417304,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-09-11T16:42:23.000Z","date":"2019-09-11","kind":"purchase","acquired":true,"shares":606061,"price":1.65,"value":1000000.65,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":22900836,"source":{"system":"sec-edgar","filing":"0001140361-19-016526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119016526/form4.xml","form_type":"4"}},{"id":3423026,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-09-04T18:24:32.000Z","date":"2019-09-04","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On September 4, 2019, the Issuer exercised its right to have M&F Group purchase 606,061 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On September 4, 2019, the Issuer exercised its right to have M&F Group purchase 606,061 shares of Common Stock for a total purchase price of $1,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.65,"exercise_date":"2019-03-18","expiration_date":"2020-03-18","underlying":"Class A common stock","underlying_shares":606061},"source":{"system":"sec-edgar","filing":"0001140361-19-016100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119016100/form4.xml","form_type":"4"}},{"id":3423025,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-09-04T18:24:32.000Z","date":"2019-09-04","kind":"purchase","acquired":true,"shares":606061,"price":1.65,"value":1000000.65,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":22294775,"source":{"system":"sec-edgar","filing":"0001140361-19-016100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119016100/form4.xml","form_type":"4"}},{"id":3430899,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-08-22T18:37:48.000Z","date":"2019-08-22","kind":"purchase","acquired":true,"shares":50000,"price":1.38,"value":69000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.365 to $1.40, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":21688714,"source":{"system":"sec-edgar","filing":"0001140361-19-015481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119015481/form4.xml","form_type":"4"}},{"id":3434205,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-08-19T19:38:30.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":150000,"price":1.306,"value":195900.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.275 to $1.32, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":21638714,"source":{"system":"sec-edgar","filing":"0001140361-19-015323","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119015323/form4.xml","form_type":"4"}},{"id":3445462,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-08-06T16:40:53.000Z","date":"2019-08-06","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On August 6, 2019, the Issuer exercised its right to have M&F Group purchase 1,212,121 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On August 6, 2019, the Issuer exercised its right to have M&F Group purchase 1,212,121 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.65,"exercise_date":"2019-03-18","expiration_date":"2020-03-18","underlying":"Class A common stock","underlying_shares":1212121},"source":{"system":"sec-edgar","filing":"0001140361-19-014349","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119014349/form4.xml","form_type":"4"}},{"id":3445461,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-08-06T16:40:53.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":1212121,"price":1.65,"value":1999999.65,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":21488714,"source":{"system":"sec-edgar","filing":"0001140361-19-014349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119014349/form4.xml","form_type":"4"}},{"id":3465102,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-07-09T16:35:41.000Z","date":"2019-07-09","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On July 9, 2019, the Issuer exercised its right to have M&F Group purchase 1,212,121 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On July 9, 2019, the Issuer exercised its right to have M&F Group purchase 1,212,121 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.65,"exercise_date":"2019-03-18","expiration_date":"2020-03-18","underlying":"Class A common stock","underlying_shares":1212121},"source":{"system":"sec-edgar","filing":"0001140361-19-012655","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119012655/form4.xml","form_type":"4"}},{"id":3465101,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-07-09T16:35:41.000Z","date":"2019-07-09","kind":"purchase","acquired":true,"shares":1212121,"price":1.65,"value":1999999.65,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":20276593,"source":{"system":"sec-edgar","filing":"0001140361-19-012655","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119012655/form4.xml","form_type":"4"}},{"id":3477946,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-06-26T08:52:04.000Z","date":"2019-06-25","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On June 25, 2019, the Issuer exercised its right to have M&F Group purchase 1,212,121 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 18, 2019, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.65. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $9.0 million. On June 25, 2019, the Issuer exercised its right to have M&F Group purchase 1,212,121 shares of Common Stock for a total purchase price of $2,000,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":1,"derivative":{"exercise_price":1.65,"exercise_date":"2019-03-18","expiration_date":"2020-03-18","underlying":"Class A common stock","underlying_shares":1212121},"source":{"system":"sec-edgar","filing":"0001140361-19-011603","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119011603/form4.xml","form_type":"4"}},{"id":3477945,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-06-26T08:52:04.000Z","date":"2019-06-25","kind":"purchase","acquired":true,"shares":1212121,"price":1.65,"value":1999999.65,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":19064472,"source":{"system":"sec-edgar","filing":"0001140361-19-011603","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119011603/form4.xml","form_type":"4"}},{"id":3480737,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-06-24T10:09:22.000Z","date":"2019-06-20","kind":"purchase","acquired":true,"shares":75000,"price":20.21,"value":1515750.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades at prices ranging from $20.14 to $20.26. The price reported above reflects the weighted average purchase price.  Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Perelman is the beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 88,032 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above."}],"balance_after":36443768,"source":{"system":"sec-edgar","filing":"0000950157-19-000737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719000737/form4.xml","form_type":"4"}},{"id":3482043,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-21T21:00:54.000Z","date":"2019-06-19","kind":"exercise","acquired":false,"shares":1555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest in equal installments of 1,555 shares on each of June 19, 2020 and June 19, 2021. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest in equal installments of 1,555 shares on each of June 19, 2020 and June 19, 2021. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 19, 2017. The balance of the award is scheduled to vest in equal installments of 1,555 shares on each of June 19, 2020 and June 19, 2021. Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":3110,"derivative":{"underlying":"Common Stock","underlying_shares":1555},"source":{"system":"sec-edgar","filing":"0000750004-19-000097","document":"wf-form4_156115084037703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000419000097/wf-form4_156115084037703.xml","form_type":"4"}},{"id":3482042,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T21:00:54.000Z","date":"2019-06-19","kind":"exercise","acquired":true,"shares":1555,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9074,"source":{"system":"sec-edgar","filing":"0000750004-19-000097","document":"wf-form4_156115084037703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000419000097/wf-form4_156115084037703.xml","form_type":"4"}},{"id":3485394,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-06-19T22:33:59.000Z","date":"2019-06-19","kind":"purchase","acquired":true,"shares":120000,"price":20.29,"value":2434800.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades at prices ranging from $20.06 to $20.55. The price reported above reflects the weighted average purchase price.  Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Perelman is the beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 88,032 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above."}],"balance_after":36368768,"source":{"system":"sec-edgar","filing":"0000950157-19-000730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719000730/form4.xml","form_type":"4"}},{"id":3488885,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-06-18T01:17:04.000Z","date":"2019-06-17","kind":"purchase","acquired":true,"shares":110000,"price":19.73,"value":2170300.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades at prices ranging from $19.41 to $19.85. The price reported above reflects the weighted average purchase price.  Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Perelman is the beneficiary and trustee of The ROP Revocable Trust dated 1/9/2018 (the \"Trust\"), which directly holds 88,032 shares of common stock. The Trust is also the sole stockholder of MacAndrews & Forbes Incorporated, which is the sole stockholder, directly or indirectly, of each of SGMS Acquisition Corporation, RLX Holdings Two LLC, SGMS Acquisition Two LLC, SGMS Acquisition Three LLC and MacAndrews & Forbes Group, LLC, which hold the remaining securities described above."}],"balance_after":36248768,"source":{"system":"sec-edgar","filing":"0000950157-19-000717","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719000717/form4.xml","form_type":"4"}},{"id":3488884,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2019-06-18T01:11:52.000Z","date":"2019-06-15","kind":"exercise","acquired":false,"shares":4338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The balance of the award is scheduled to vest on June 15, 2020 (4,339 shares). Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The balance of the award is scheduled to vest on June 15, 2020 (4,339 shares). Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents vesting of one-fourth of restricted stock units granted on June 15, 2016. The balance of the award is scheduled to vest on June 15, 2020 (4,339 shares). Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":4339,"derivative":{"underlying":"Common Stock","underlying_shares":4338},"source":{"system":"sec-edgar","filing":"0000950157-19-000716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719000716/form4.xml","form_type":"4"}},{"id":3488883,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Restricted Stock Units","published_at":"2019-06-18T01:11:52.000Z","date":"2019-06-13","kind":"exercise","acquired":false,"shares":696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 13, 2018. The balance of the award is scheduled to vest in equal installments of 697 shares on each of June 13, 2020, June 13, 2021 and June 13, 2022. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 13, 2018. The balance of the award is scheduled to vest in equal installments of 697 shares on each of June 13, 2020, June 13, 2021 and June 13, 2022. Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 13, 2018. The balance of the award is scheduled to vest in equal installments of 697 shares on each of June 13, 2020, June 13, 2021 and June 13, 2022. Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":2091,"derivative":{"underlying":"Common Stock","underlying_shares":696},"source":{"system":"sec-edgar","filing":"0000950157-19-000716","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719000716/form4.xml","form_type":"4"}},{"id":3488882,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-06-18T01:11:52.000Z","date":"2019-06-15","kind":"exercise","acquired":true,"shares":4338,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7519,"source":{"system":"sec-edgar","filing":"0000950157-19-000716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719000716/form4.xml","form_type":"4"}},{"id":3488881,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-06-18T01:11:52.000Z","date":"2019-06-13","kind":"exercise","acquired":true,"shares":696,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3181,"source":{"system":"sec-edgar","filing":"0000950157-19-000716","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000095015719000716/form4.xml","form_type":"4"}},{"id":3493538,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-12T20:43:05.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units are scheduled to vest beginning on June 12, 2020 (1,927 shares) and the balance in three installments on June 12, 2021 (1,928 shares), June 12, 2022 (1,927 shares) and June 12, 2023 (1,928 shares). Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units are scheduled to vest beginning on June 12, 2020 (1,927 shares) and the balance in three installments on June 12, 2021 (1,928 shares), June 12, 2022 (1,927 shares) and June 12, 2023 (1,928 shares). Each unit converts into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units are scheduled to vest beginning on June 12, 2020 (1,927 shares) and the balance in three installments on June 12, 2021 (1,928 shares), June 12, 2022 (1,927 shares) and June 12, 2023 (1,928 shares). Each unit converts into a share of common stock on a one-for-one basis."}],"balance_after":7710,"derivative":{"underlying":"Common Stock","underlying_shares":7710},"source":{"system":"sec-edgar","filing":"0000750004-19-000060","document":"wf-form4_156037217088390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000419000060/wf-form4_156037217088390.xml","form_type":"4"}},{"id":3493537,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-12T20:43:05.000Z","date":"2019-06-10","kind":"exercise","acquired":false,"shares":2485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 10, 2015. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 10, 2015. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents vesting of one-fourth of restricted stock units granted on June 10, 2015. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2485},"source":{"system":"sec-edgar","filing":"0000750004-19-000060","document":"wf-form4_156037217088390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000419000060/wf-form4_156037217088390.xml","form_type":"4"}},{"id":3493536,"issuer":{"id":9758,"kind":"organization","name":"Light & Wonder, Inc.","symbol":"ASX:LNW"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-12T20:43:05.000Z","date":"2019-06-10","kind":"exercise","acquired":true,"shares":2485,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2485,"source":{"system":"sec-edgar","filing":"0000750004-19-000060","document":"wf-form4_156037217088390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/750004/000075000419000060/wf-form4_156037217088390.xml","form_type":"4"}},{"id":3497891,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-07T19:28:27.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":20000,"price":23.5134,"value":470268.0,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions were executed in multiple trades. The purchase price of $23.5134 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $23.01 to $23.75 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Of the 46,223,321 shares of Class A Common Stock reported herein, (i) 41,676,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated (\"M&F\") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control.  The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F."}],"balance_after":46223321,"source":{"system":"sec-edgar","filing":"0001209191-19-035673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119035673/doc4.xml","form_type":"4"}},{"id":3497890,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-07T19:28:27.000Z","date":"2019-06-05","kind":"purchase","acquired":true,"shares":13228,"price":23.3705,"value":309144.974,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions were executed in multiple trades. The purchase price of $23.3705 reported in Column 4 is the weighted average purchase price for the 13,228 shares acquired by the Reporting Person within a range of $23.28 to $23.49 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":46203321,"source":{"system":"sec-edgar","filing":"0001209191-19-035673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119035673/doc4.xml","form_type":"4"}},{"id":3497889,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-07T19:28:27.000Z","date":"2019-06-05","kind":"purchase","acquired":true,"shares":16772,"price":23.0493,"value":386582.8596,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions were executed in multiple trades. The purchase price of $23.0493 reported in Column 4 is the weighted average purchase price for the 16,772 shares acquired by the Reporting Person within a range of $22.48 to $23.27 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":46190093,"source":{"system":"sec-edgar","filing":"0001209191-19-035673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119035673/doc4.xml","form_type":"4"}},{"id":3505595,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-03T17:58:50.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":30000,"price":21.1717,"value":635151.0,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions were executed in multiple trades. The purchase price of $21.1717 reported in Column 4 is the weighted average purchase price for the 30,000 shares acquired by the Reporting Person within a range of $20.73 to $21.50 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Of the 46,173,321 shares of Class A Common Stock reported herein, (i) 41,626,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated (\"M&F\") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control.  The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F."}],"balance_after":46173321,"source":{"system":"sec-edgar","filing":"0001209191-19-034035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119034035/doc4.xml","form_type":"4"}},{"id":3505594,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-03T17:58:50.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":60000,"price":21.246,"value":1274760.0,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions were executed in multiple trades. The purchase price of $21.2460 reported in Column 4 is the weighted average purchase price for the 60,000 shares acquired by the Reporting Person within a range of $20.89 to $21.44 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":46143321,"source":{"system":"sec-edgar","filing":"0001209191-19-034035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119034035/doc4.xml","form_type":"4"}},{"id":3505593,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-03T17:58:50.000Z","date":"2019-05-30","kind":"purchase","acquired":true,"shares":14257,"price":21.8744,"value":311863.3208,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions were executed in multiple trades. The purchase price of $21.8744 reported in Column 4 is the weighted average purchase price for the 14,257 shares acquired by the Reporting Person within a range of $21.76 to $22.04 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":46083321,"source":{"system":"sec-edgar","filing":"0001209191-19-034035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119034035/doc4.xml","form_type":"4"}},{"id":3505592,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-03T17:58:50.000Z","date":"2019-05-30","kind":"purchase","acquired":true,"shares":35743,"price":21.4246,"value":765779.4778,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions were executed in multiple trades. The purchase price of $21.4246 reported in Column 4 is the weighted average purchase price for the 35,743 shares acquired by the Reporting Person within a range of $20.76 to $21.75 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":46069064,"source":{"system":"sec-edgar","filing":"0001209191-19-034035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119034035/doc4.xml","form_type":"4"}},{"id":3523403,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Call Option (right to buy)","published_at":"2019-05-16T07:54:40.000Z","date":"2019-05-15","kind":"other","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 11, 2018, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On May 15, 2019, the Issuer exercised its right to have M&F Group purchase the final 1,358,698 shares of Common Stock for a total purchase price of $2,500,000 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 11, 2018, M&F Group entered into a letter agreement (the \"Letter Agreement\"), with the Issuer for M&F Group's commitment to purchase, at the Issuer's option, exercisable on demand during a one-year period (the \"Investment Period\"), the Company's Class A common stock, par value $0.01 per share (\"Common Stock\") at a per share price of $1.84, which is equal to the closing price of the Common Stock for the trading day preceding the date of the Letter Agreement. The Letter Agreement also permits M&F Group to exercise an option to purchase Common Stock at the same price up to three times during the Investment Period. The aggregate amount of Common Stock that may be purchased by M&F Group is limited to $10.0 million. On May 15, 2019, the Issuer exercised its right to have M&F Group purchase the final 1,358,698 shares of Common Stock for a total purchase price of $2,500,000 in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":0,"derivative":{"exercise_price":1.84,"exercise_date":"2018-12-11","expiration_date":"2019-12-11","underlying":"Class A common stock","underlying_shares":1358698},"source":{"system":"sec-edgar","filing":"0001140361-19-009238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119009238/form4.xml","form_type":"4"}},{"id":3523402,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"ten_percent_owner":true}}],"security":"Class A common stock","published_at":"2019-05-16T07:54:40.000Z","date":"2019-05-15","kind":"purchase","acquired":true,"shares":1358698,"price":1.84,"value":2500004.32,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The ROP Revocable Trust dated 1/9/2018 (the \"ROP Revocable Trust\"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated (\"M&F Inc.\"), which is the parent of MFV Holdings One LLC (\"MFV\") and MacAndrews & Forbes LLC (\"M&F LLC\"), which is the parent of M&F Group. M&F Group and MFV hold the securities described above. Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group and MFV may be deemed to be directors by deputization of vTv Therapeutics Inc. (the \"Issuer\") by virtue of their relationship with Steven M. Cohen and Paul G. Savas, directors of the Issuer, and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. (\"M&F TTP\"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC."}],"balance_after":17852351,"source":{"system":"sec-edgar","filing":"0001140361-19-009238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1186472/000114036119009238/form4.xml","form_type":"4"}},{"id":3562084,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-05T17:08:56.000Z","date":"2019-04-05","kind":"purchase","acquired":true,"shares":25000,"price":21.2805,"value":532012.5,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions were executed in multiple trades. The purchase price of $21.2805 reported in Column 4 is the weighted average purchase price for the 25,000 shares acquired by the Reporting Person within a range of $20.72 to $21.59 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Of the 46,033,321 shares of Class A Common Stock reported herein, (i) 41,486,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated (\"M&F\") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control.  The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F."}],"balance_after":46033321,"source":{"system":"sec-edgar","filing":"0001209191-19-023841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119023841/doc4.xml","form_type":"4"}},{"id":3562083,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-05T17:08:56.000Z","date":"2019-04-04","kind":"purchase","acquired":true,"shares":20000,"price":21.0271,"value":420542.0,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions were executed in multiple trades. The purchase price of $21.0271 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $20.60 to $21.20 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":46008321,"source":{"system":"sec-edgar","filing":"0001209191-19-023841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119023841/doc4.xml","form_type":"4"}},{"id":3562082,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-05T17:08:56.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":20000,"price":20.9555,"value":419110.0,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions were executed in multiple trades. The purchase price of $20.9555 reported in Column 4 is the weighted average purchase price for the 20,000 shares acquired by the Reporting Person within a range of $20.65 to $21.115 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":45988321,"source":{"system":"sec-edgar","filing":"0001209191-19-023841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119023841/doc4.xml","form_type":"4"}},{"id":3570308,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-02T19:06:50.000Z","date":"2019-04-02","kind":"purchase","acquired":true,"shares":21762,"price":20.5488,"value":447182.9856,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions were executed in multiple trades. The purchase price of $20.5488 reported in Column 4 is the weighted average purchase price for the 21,762 shares acquired by the Reporting Person within a range of $20.45 to $20.75 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Of the 45,968,321 shares of Class A Common Stock reported herein, (i) 41,421,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated (\"M&F\") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control.  The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F."}],"balance_after":45968321,"source":{"system":"sec-edgar","filing":"0001209191-19-022747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119022747/doc4.xml","form_type":"4"}},{"id":3570307,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-02T19:06:50.000Z","date":"2019-04-02","kind":"purchase","acquired":true,"shares":23238,"price":20.2702,"value":471038.9076,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions were executed in multiple trades. The purchase price of $20.2702 reported in Column 4 is the weighted average purchase price for the 23,238 shares acquired by the Reporting Person within a range of $19.73 to $20.44 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":45946559,"source":{"system":"sec-edgar","filing":"0001209191-19-022747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119022747/doc4.xml","form_type":"4"}},{"id":3570306,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-02T19:06:50.000Z","date":"2019-04-01","kind":"purchase","acquired":true,"shares":50090,"price":20.2351,"value":1013576.159,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions were executed in multiple trades. The purchase price of $20.2351 reported in Column 4 is the weighted average purchase price for the 50,090 shares acquired by the Reporting Person within a range of $20.05 to $20.47 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":45923321,"source":{"system":"sec-edgar","filing":"0001209191-19-022747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119022747/doc4.xml","form_type":"4"}},{"id":3570305,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-02T19:06:50.000Z","date":"2019-04-01","kind":"purchase","acquired":true,"shares":19910,"price":19.7406,"value":393035.346,"ownership":{"direct":false,"nature":"See footnote 5"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions were executed in multiple trades. The purchase price of $19.7406 reported in Column 4 is the weighted average purchase price for the 19,910 shares acquired by the Reporting Person within a range of $19.05 to $20.04 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":45873231,"source":{"system":"sec-edgar","filing":"0001209191-19-022747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119022747/doc4.xml","form_type":"4"}},{"id":3579039,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-03-26T19:30:57.000Z","date":"2019-03-26","kind":"purchase","acquired":true,"shares":2800,"price":21.707,"value":60779.6,"ownership":{"direct":false,"nature":"See footnote 3"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions were executed in multiple trades. The purchase price of $21.7070 reported in Column 4 is the weighted average purchase price for the 2,800 shares acquired by the Reporting Person within a range of $21.64 to $21.77 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of the 45,853,321 shares of Class A Common Stock reported herein, (i) 41,306,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated (\"M&F\") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control.  The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F."}],"balance_after":45853321,"source":{"system":"sec-edgar","filing":"0001209191-19-021372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119021372/doc4.xml","form_type":"4"}},{"id":3579038,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-03-26T19:30:57.000Z","date":"2019-03-26","kind":"purchase","acquired":true,"shares":32200,"price":21.3711,"value":688149.42,"ownership":{"direct":false,"nature":"See footnote 3"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions were executed in multiple trades. The purchase price of $21.3711 reported in Column 4 is the weighted average purchase price for the 32,200 shares acquired by the Reporting Person within a range of $20.64 to $21.63 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."}],"balance_after":45850521,"source":{"system":"sec-edgar","filing":"0001209191-19-021372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119021372/doc4.xml","form_type":"4"}},{"id":3580307,"issuer":{"id":115224,"kind":"organization","name":"REVLON INC /DE/","symbol":"REVRQ"},"owners":[{"id":122511,"kind":"person","name":"PERELMAN RONALD O","position":1,"cik":"0001186472","reported_name":"PERELMAN RONALD O","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2019-03-25T18:42:31.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":40000,"price":20.5254,"value":821016.0,"ownership":{"direct":false,"nature":"See footnote 4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions were executed in multiple trades. The purchase price of $20.5254 reported in Column 4 is the weighted average purchase price for the 40,000 shares acquired by the Reporting Person within a range of $20.08 to $20.95 per share. The Reporting Person hereby undertakes to provide to the Staff of the SEC, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price within the price range noted above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Of the 45,818,321 shares of Class A Common Stock reported herein, (i) 41,271,969 shares of Class A Common Stock are owned by MacAndrews & Forbes Incorporated (\"M&F\") or its wholly-owned subsidiaries; and (ii) 4,546,352 shares of Class A Common Stock are owned by Perelman Trust Company, LLC, over which M&F exercises voting control.  The ROP Revocable Trust dated 1/9/2018, of which Ronald O. Perelman is the sole trustee and beneficiary, is the sole stockholder of M&F."}],"balance_after":45818321,"source":{"system":"sec-edgar","filing":"0001209191-19-021232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887921/000120919119021232/doc4.xml","form_type":"4"}}],"next_cursor":"2019-03-25T18:42:31.000000Z,3580307"}